Cargando…
Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer
Whole exome sequencing (WES), targeted gene panel sequencing and single nucleotide polymorphism (SNP) arrays are increasingly used for the identification of actionable alterations that are critical to cancer care. Here, we compared The Cancer Genome Atlas (TCGA) and the Genomics Evidence Neoplasia I...
Autores principales: | Kaur, Pushpinder, Porras, Tania B., Ring, Alexander, Carpten, John D., Lang, Julie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365517/ https://www.ncbi.nlm.nih.gov/pubmed/30728399 http://dx.doi.org/10.1038/s41598-018-37574-8 |
Ejemplares similares
-
Challenges in using liquid biopsies for gene expression profiling
por: Porras, Tania B., et al.
Publicado: (2018) -
EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer
por: Ring, Alexander, et al.
Publicado: (2020) -
A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer
por: Kaur, Pushpinder, et al.
Publicado: (2020) -
GENIE
por: Andreopoulos, Costas
Publicado: (2022) -
Génie climatique
por: Recknagel, Hermann, et al.
Publicado: (2013)